Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients
Description
CONCLUSION: This proof-of-concept study shows a potential positive risk-benefit profile for voclosporin in immunocompromised patients with SARS-CoV-2 infection. These results warrant further investigations on voclosporin to establish an equipoise
